Navigation Links
Nanotech researchers' 2-step method shows promise in fighting pancreatic cancer
Date:11/15/2013

y Zink, a UCLA professor of chemistry and biochemistry, and Dr. Jeffrey Brinker, a University of New Mexico professor of chemical and nuclear engineering, sought to place chemotherapy drugs into nanoparticles that could more directly target pancreatic cancer cells, but they first needed to find a way to get those nanoparticles through the sites of vascular obstruction caused by pericytes, which restrict access to the cancer cells.

Through experimentation, they discovered they could interfere with a cellular signaling pathway the communication mechanism between cells that governs the pericytes' attraction to the tumor blood vessels. By creating nanoparticles that effectively bind a high load of the signaling pathway inhibitor, the researchers were able to develop a first wave of nanoparticles that would separate the pericytes from the endothelial cells on the blood vessel. This would open the vascular gate for the next wave of nanoparticles, which carry the chemotherapeutic agent to the cancer cells inside the tumor.

To test this nanotherapy, the researchers used immuno-compromised mice in which they grew human pancreatic tumors called xenografts under the skin. With the two-wave method, the xenograft tumors had a significantly higher rate of shrinkage than tumors exposed only to chemotherapy given as a free drug or carried in nanoparticles without first-wave treatment.

"This two-wave nanotherapy is an existing example of how we seek to improve the delivery of chemotherapy drugs to their intended targets using nanotechnology to provide an engineered approach," said Nel, chief of UCLA's division of nanomedicine. "It shows how the physical and chemical principles of nanotechnology can be integrated with the biological sciences to help cancer patients by increasing the effectiveness of chemotherapy while also reducing side effects and toxicity. This two-wave treatment approach can also address biological impediments in nanotherapies
'/>"/>

Contact: Shaun Mason
smason@mednet.ucla.edu
310-206-2805
University of California - Los Angeles
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Giving transplanted cells a nanotech checkup
2. Furnace Accelerator Startup SiO2 Nanotech Develops Anti-Fogging Technology for Variety of Applications
3. Outlook with Ben Kingsley Exploring Role of Nanotechnology in Medicine for Upcoming Report
4. Nanotech system, cellular heating may improve treatment of ovarian cancer
5. CWRU researchers aim nanotechnology at micrometastases
6. NIH awards $20 million over 5 years to train next generation of global health researchers
7. Researchers develop a new cell and animal model of inflammatory breast cancer
8. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
9. Researchers Find Gene Mutations That May Be a Key to Autism
10. Researchers find evidence of banned antibiotics in poultry products
11. NJ stroke researchers report advances in spatial neglect research at AAN Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... AxoGen, Inc. (NASDAQ: AXGN) , a ... repair market, reported record revenue of $4.79 million for ... $2.98 million in the year-ago fourth quarter demonstrating the ... “Our strong fourth quarter revenue growth reflects the market’s ... is driving increased surgeon adoption of our unique product ...
(Date:3/5/2015)... March 05, 2015 HomeCEUConnection.com ... March with extra savings on their nutrition ... of health and nutrition, HomeCEUConnection.com is offering ... the promo code, NUTRITION2015 . , ... , HomeCEUConnection.com provides high-quality continuing education ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 TCS Healthcare ... solutions for the population health management arena, is pleased ... case management software, ACUITY Advanced Care™ (ACUITY) version 7.20. ... improved performance and the advantages of automation. , The ... ET, will be led by Jeff Frater, RN, BSN, ...
(Date:3/5/2015)... 2015 University of Western States ... 1904, has launched a new center of excellence ... The Northwest Center for Lifestyle and Functional Medicine ... outreach, and conduct research in the areas of ... nutrition. The center will target efforts on the ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 INTEGRATED ... healthcare organizations to participate in its 2015 Children’s ... from executive and director-level positions, and the survey ... Last year’s report featured data on 60 executive ... children’s healthcare organizations and 7 subsidiary children’s hospitals. ...
Breaking Medicine News(10 mins):Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 2Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 3Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 4Health News:HomeCEUConnection.com Offers Nutrition CEUs this March to Celebrate Nutrition Month 2Health News:Complimentary Webinar to Explore Enhanced Version of Premier Case Management Software 2Health News:Complimentary Webinar to Explore Enhanced Version of Premier Case Management Software 3Health News:University of Western States Launches Northwest Center for Lifestyle and Functional Medicine 2Health News:Participation Is Now Open For INTEGRATED Healthcare Strategies 2015 Children’s Hospitals Executive Compensation Survey 2
... those who have been hospitalized, risk may double over 7 ... Certain depressed patients who suffer from heart disease have nearly ... with other depressed patients, researchers say. , The patients ... severe depression within a few weeks of being hospitalized for ...
... of Tropical Medicine (LSTM) and Liverpool Associates in Tropical ... UK,s Department for International Development (DFID) to set up ... The IHLC will act as a ,one-stop-shop, source ... developers of links and those wishing to strengthen existing ...
... complications seen with ,after-hours, procedures, study finds , MONDAY, ... slot to undergo an orthopedic procedure may lower your ... new study has found. , The study, published ... Bone and Joint Surgery , found little difference otherwise ...
... Regurin(R) XL (trospium chloride), a,once-daily, prolonged-release capsule to ... the UK. Regurin(R) XL provides rapid,significant and consistent improvements ... for central nervous system (CNS) side effects(2-7). , ... is a condition that results from,sudden, involuntary contraction of ...
... ... supplier of medical devices, today announced FDA clearance of new RT50 wireless stimulator modules ... stimulation (FES) motorized ergometer system. , ... Baltimore, MD(PRWEB) September 5, 2009 -- Restorative Therapies, Inc., a designer ...
... , , ... Cell Technologies, Inc., ("Stemedica"), a world leader in stem cell research ... breakthrough stem cell and related technology. The Jordanian Stem Cell ... the technology from Stemedica,s wholly-owned subsidiary, Stemedica International, S.A. The ...
Cached Medicine News:Health News:Severe, Lasting Depression Tied to Heart Patient Deaths 2Health News:Creation of international health links center 2Health News:Let Orthopedic Surgery Wait Until Morning When Possible 2Health News:REGURIN(R) XL (trospium chloride) Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 2Health News:REGURIN(R) XL (trospium chloride) Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 3Health News:REGURIN(R) XL (trospium chloride) Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 4Health News:REGURIN(R) XL (trospium chloride) Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 5Health News:Restorative Therapies, Inc., Receives FDA Clearance for RT300 Enhancements 2Health News:Restorative Therapies, Inc., Receives FDA Clearance for RT300 Enhancements 3Health News:The Jordanian Stem Cell Company Acquires Stem Cell Technology From Stemedica International S.A. 2Health News:The Jordanian Stem Cell Company Acquires Stem Cell Technology From Stemedica International S.A. 3
(Date:3/5/2015)... Research and Markets ( http://www.researchandmarkets.com/research/5sqnn3/global_rising ) ... Stars Outlook 2015" report to their offering. ... sought after with fresh vigor as new targets , ... poised to bring a paradigm change in the way ... Stem cell therapy/Regenerative Medicine space. The number ...
(Date:3/5/2015)... 5, 2015 According to a ... Product (Systems and Disposables), by Type (Invasive, Minimally Invasive, ... and Ambulatory Sites) - Analysis & Global Forecast to ... expected to reach $1,107.4 Million by 2019 from $887.8 ... a CAGR of 4.5% during the forecast period. ...
(Date:3/5/2015)... 2015 Research and Markets ( ... PharmaBiotech,s new report "Therapeutic Drug Monitoring - ... This report deals with therapeutic ... improving patient care by monitoring drug levels in ... drugs for improving outcome. TDM is viewed as ...
Breaking Medicine Technology:Global Pharma Rising Stars Outlook 2015 2Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 2Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 3Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 4Global Therapeutic Drug Monitoring Report 2015 - Technologies, Markets, and Companies Analysis 2014-2024 2
... 2011 - Bayer HealthCare Pharmaceuticals has become aware of a ... and swabsticks manufactured by the Triad Group and marketed under ... wants to ensure that U.S. patients and physicians using Bayer,s ... The recall of the Triad Group alcohol prep products ...
... U.S. Food and Drug Administration today approved Abstral (fentanyl) ... cancer.  Fentanyl immediate-release transmucosal medications are administered on the ... gums, tongue), or the nasal passages or throat where ...   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) "This is an ...
Cached Medicine Technology:Important Information for Betaseron® (interferon beta 1-b) Consumers Regarding Triad Group's Alcohol Prep Products 2Important Information for Betaseron® (interferon beta 1-b) Consumers Regarding Triad Group's Alcohol Prep Products 3FDA Approves Opioid Analgesic to Help Cancer Patients Manage Pain 2FDA Approves Opioid Analgesic to Help Cancer Patients Manage Pain 3
The Mini Vidas is a compact version of the Vidas system with a built-in computer, keyboard and printer. Two independent sections each accept six tests and can process up to 12 samples simultaneously....
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: